Bellevue Group’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,287
Closed -$106K 161
2022
Q4
$106K Buy
1,287
+381
+42% +$31.4K ﹤0.01% 161
2022
Q3
$71K Buy
+906
New +$72.4K ﹤0.01% 164
2018
Q1
Sell
-10,000
Closed -$326K 126
2017
Q4
$326K Sell
10,000
-21,000
-68% -$728K 0.03% 132
2017
Q3
$1.48M Buy
+31,000
New +$1.51M 0.15% 97

Other funds holding ACHC

Bellevue Group's ACHC Position: Q1 2023 in Review

Bellevue Group sold out of Acadia Healthcare (ACHC) in Q1 2023, closing a stake of 1,287 shares — an estimated $106K sold.

Bellevue Group first reported a position in ACHC in Q3 2017 and held it in 4 quarters. The position peaked at $1.48M in Q3 2017. 310 funds tracked by Wall St. Rank hold ACHC as of Q1 2023.

  • Bellevue Group reported no remaining Acadia Healthcare position as of Q1 2023 after selling out during the quarter.
  • Bellevue Group sold 1,287 Acadia Healthcare shares in Q1 2023, an estimated $106K.
  • Bellevue Group first reported a position in Acadia Healthcare in Q3 2017 and held it in 4 quarters.
  • Bellevue Group's Acadia Healthcare position peaked at $1.48M in Q3 2017.
  • 310 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2023.

Based on Bellevue Group's 13F filing for Q1 2023, filed 15 May 2023.